Cargando…
Defective AMPK regulation of cholesterol metabolism accelerates atherosclerosis by promoting HSPC mobilization and myelopoiesis
OBJECTIVES: Dysregulation of cholesterol metabolism in the liver and hematopoietic stem and progenitor cells (HSPCs) promotes atherosclerosis development. Previously, it has been shown that HMG-CoA-Reductase (HMGCR), the rate-limiting enzyme in the mevalonate pathway, can be phosphorylated and inact...
Autores principales: | Lee, Man K.S., Cooney, Olivia D., Lin, Xuzhu, Nadarajah, Shaktypreya, Dragoljevic, Dragana, Huynh, Kevin, Onda, Danise-Ann, Galic, Sandra, Meikle, Peter J., Edlund, Thomas, Fullerton, Morgan D., Kemp, Bruce E., Murphy, Andrew J., Loh, Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124714/ https://www.ncbi.nlm.nih.gov/pubmed/35562083 http://dx.doi.org/10.1016/j.molmet.2022.101514 |
Ejemplares similares
-
Cholesterol Efflux Pathways Regulate Myelopoiesis: A Potential Link to Altered Macrophage Function in Atherosclerosis
por: Murphy, Andrew James, et al.
Publicado: (2014) -
Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes
por: Yang, Chieh-Hsin, et al.
Publicado: (2021) -
Roles of bone-derived hormones in type 2 diabetes and cardiovascular pathophysiology
por: Lin, Xuzhu, et al.
Publicado: (2020) -
Inhibition of JAK2 Suppresses Myelopoiesis and Atherosclerosis in Apoe(−/−) Mice
por: Tang, Yang, et al.
Publicado: (2020) -
Re-examining HSPC1 inhibitors
por: Lee, Sheah Lin, et al.
Publicado: (2017)